Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Oxford OXLCI Stock Analysis 086 Gain What to Watch 20260519 KALA BIO KALA Q4 2025 Earnings Beat Revenue NA EPS 3350 Precipio PRPO Surges 114 Nearing 2695 Resistance 20260519 Fold Holdings FLD Stock Steady at 124 Support at 118 20260519 Eli Lilly Stock Edges Higher on Nearly 4 Billion Vaccine Push into Infectious Disease RD SpaceX Successfully Launches Starship Test Flight on Second Attempt Oura Health Smart Ring Maker Files Confidentially for IPO Galeries Lafayette Closes Beijing Store After 13 Years Refocuses on Chinese Market Strategy Genpact CEO Highlights AIDriven Reduction in IT Workload and Employment Growth RY Q1 2026 Earnings EPS Beats Estimates by 30 Amid Resilient Banking Operations Modular Medical Inc MODD Q3 2025 Earnings Narrowed Loss Per Share Despite Surprise Miss Stock Rises 458 CHD Q1 2026 Earnings EPS Beats Estimates Stock Gains 14 SRE Q1 2026 Earnings EPS Slightly Misses Estimates Shares Rise VLTO Q1 2026 Earnings EPS Beat of 435 Despite Stock Decline Acrivon Therapeutics ACRV Slides 171 as Stock Nears Critical Support Zone SOLV Energy Inc MWH Slides 35 Support Test Ahead as Resistance Holds Palantir Technologies PLTR Holds Steady Near Key Levels as Investors Weigh Growth Prospects Ebang International Holdings EBON Slips 43 as Support Level at 19 Comes into Focus Feds Powell Vows No Shadow Chair Role as Potential Warsh Conflict Looms Over Next Meeting SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaways Valuation on Debut Polymarket Traders Suggest PayPal Leadership Transition Casts Shadow Over Q1 Results India Intensifies Ebola Screening at Borders and Airports as Health Ministry Bolsters Preparedness Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss KRRO Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction INTZ Q1 2026 Earnings A Significant EPS Miss Meets a Surprising Stock Bounce SEPN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline